{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T16:44:46Z","timestamp":1782492286823,"version":"3.54.5"},"reference-count":115,"publisher":"Informa UK Limited","issue":"6","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230067"],"award-info":[{"award-number":["82230067"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment","award":["2021B1212040004"],"award-info":[{"award-number":["2021B1212040004"]}]},{"name":"Zhuhai Industrial Core and Key Technology Tackling Direction Project","award":["ZH22044702190126HJL"],"award-info":[{"award-number":["ZH22044702190126HJL"]}]},{"name":"Science and Technology Planning Project of Guangzhou","award":["SL2024A03J00598"],"award-info":[{"award-number":["SL2024A03J00598"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2024,6,2]]},"DOI":"10.1080\/14737140.2024.2346624","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T08:12:45Z","timestamp":1713859965000},"page":"423-434","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review"],"prefix":"10.1080","volume":"24","author":[{"given":"Suqi","family":"Zhu","sequence":"first","affiliation":[{"name":"Zhuhai Interventional Medical Center, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahan","family":"Yu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqi","family":"Yang","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[{"name":"Zhuhai Precision Medical Center, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingkai","family":"Lai","sequence":"additional","affiliation":[{"name":"Zhuhai Interventional Medical Center, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieren","family":"Zhong","sequence":"additional","affiliation":[{"name":"Zhuhai Interventional Medical Center, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoguang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligong","family":"Lu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Liu","sequence":"additional","affiliation":[{"name":"Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai Institute of Translational Medicine, Zhuhai Clinical Medical College of Jinan University (Zhuhai People\u2019s Hospital), Zhuhai, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2008.09.007"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1028363"},{"issue":"2","key":"e_1_3_5_6_1","first-page":"288","article-title":"Standard for diagnosis and treatment of primary liver cancer (2022 edition)","volume":"38","author":"NationaI Health Commission of the People\u2019s Republic of China","year":"2022","unstructured":"NationaI Health Commission of the People\u2019s Republic of China. Standard for diagnosis and treatment of primary liver cancer (2022 edition). J Clin Hepatol. 2022;38(2):288\u2013303.","journal-title":"J Clin Hepatol"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33588"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21492"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-med-090514-013832"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2013.09.001"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.7753"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S16316"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1177\/1073274817744621"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2021.01091"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v21.i13.3843"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.04.061"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.12818"},{"issue":"1","key":"e_1_3_5_19_1","first-page":"1","article-title":"Chinese expert consensus on whole course management of liver function in liver cancer transformation therapy (2022 edition)","volume":"10","author":"Meng QH","year":"2022","unstructured":"Meng QH, Yang ZQ, Zhu ZY, et al. Chinese expert consensus on whole course management of liver function in liver cancer transformation therapy (2022 edition). Electronic J Liver Cancer. 2022 Dec 5;10(1):1\u20139.","journal-title":"Electronic J Liver Cancer"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0186-y"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i47.8069"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915745"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2021.01083"},{"issue":"12","key":"e_1_3_5_24_1","first-page":"1442","article-title":"Is salvage liver resection necessary for initially unresectable hepatocellular carcinoma patients downstaged by Transarterial Chemoembolization? Ten years of experience","volume":"21","author":"Zhang Y","year":"2016","unstructured":"Zhang Y, Huang G, Wang Y, et al. Is salvage liver resection necessary for initially unresectable hepatocellular carcinoma patients downstaged by Transarterial Chemoembolization? Ten years of experience. Oncology. 2016 Dec;21(12):1442\u20131449.","journal-title":"Oncology"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.02.008"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/17588359211002720"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.1694"},{"issue":"6","key":"e_1_3_5_28_1","first-page":"1658","article-title":"Neoadjuvant therapy and immunotherapy strategies for hepatocellular carcinoma","volume":"10","author":"Zhang T","year":"2020","unstructured":"Zhang T, Zhang L, Xu Y, et al. Neoadjuvant therapy and immunotherapy strategies for hepatocellular carcinoma. Am J Cancer Res. 2020;10(6):1658\u20131667.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.11.030"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-014-0978-3"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-007-9549-7"},{"issue":"3","key":"e_1_3_5_32_1","first-page":"70","article-title":"The application of hepatic artery infusion chemotherapy in the transformation therapy of liver cancer: summary of experience from the cancer prevention and treatment center of sun yat sen university","volume":"13","author":"Chen MS","year":"2021","unstructured":"Chen MS, Yuan YF, Guo RP, et al. The application of hepatic artery infusion chemotherapy in the transformation therapy of liver cancer: summary of experience from the cancer prevention and treatment center of sun yat sen university. Chinese J Med Frontiers. 2021 Jan 7;13(3):70\u201376.","journal-title":"Chinese J Med Frontiers"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11081489"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2004.04.002"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076388"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.5.498"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.1010824"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.44.5643"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.0250"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-03000-1"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-019-02406-3"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.184.3.01840906"},{"key":"e_1_3_5_43_1","first-page":"59","article-title":"Guidelines for the diagnosis and treatment of primary liver cancer (2020)","volume":"4","author":"Guidelines Working Committee of the Chinese Clinical Oncology Society (CSCO)","year":"2020","unstructured":"Guidelines Working Committee of the Chinese Clinical Oncology Society (CSCO). Guidelines for the diagnosis and treatment of primary liver cancer (2020). People\u2019s Health Pub House. 2020 Jun 1;4:59\u201370.","journal-title":"People\u2019s Health Pub House"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15010"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1159\/000508724"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051887"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.211545"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1159\/000514174"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.619461"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.618206"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314138"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-017-1874-z"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.5009\/gnl19367"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222312880"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1159\/000367746"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1159\/000516491"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1159\/000342402"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30078-5"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.019"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29913"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-017-9799-9"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0019"},{"issue":"7","key":"e_1_3_5_63_1","first-page":"754","article-title":"China anti-cancer association. Chinese expert consensus on hepatic arterial infusion chemotherapy for hepatocellular carcinoma (2021 edition)","volume":"20","author":"Chinese Society of Liver Cancer","year":"2021","unstructured":"Chinese Society of Liver Cancer. China anti-cancer association. Chinese expert consensus on hepatic arterial infusion chemotherapy for hepatocellular carcinoma (2021 edition). Chinese J Digest Surg. 2021;20(7):754\u2013759.","journal-title":"Chinese J Digest Surg"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30207-1"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00573-2"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0708857"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70285-7"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2011.12.006"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.5197"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw323"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyr037"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu155"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e16603"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.08.166"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00604-5"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e16593"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1080\/14737140.2023.2181162"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijsu.2017.06.082"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6653-9"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1872-034X.2011.00943.x"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-015-0504-3"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.02704.x"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1666805"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0251-2"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30585-4"},{"issue":"4","key":"e_1_3_5_86_1","first-page":"20","article-title":"Hepatic artery infusion chemotherapy for advanced primary liver cancer","volume":"6","author":"Guo JH","unstructured":"Guo JH, Zhu X. Hepatic artery infusion chemotherapy for advanced primary liver cancer. Electronic J Liver Tumor. 2019 Apr 21;6(4):20\u201323.","journal-title":"Electronic J Liver Tumor"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2007.05120.x"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13633"},{"key":"e_1_3_5_89_1","first-page":"155","article-title":"Studies on late primary adenocarcinoma of lung treated by methods of nourishing yin to replenish fluid and warming Yang to benefit Qi","volume":"36","author":"Liu JX","year":"1995","unstructured":"Liu JX, Shi ZM, Xu ZY. Studies on late primary adenocarcinoma of lung treated by methods of nourishing yin to replenish fluid and warming Yang to benefit Qi. Tradit Chin Med. 1995;36:155.","journal-title":"Tradit Chin Med"},{"key":"e_1_3_5_90_1","first-page":"21","article-title":"The clinical observation of feiliuping paste curing advanced lung cancer \u2013 and clinical analysis of 339 cases","volume":"4","author":"Piao BK","year":"1991","unstructured":"Piao BK, Tang WX, Zhang ZQ, et al. The clinical observation of feiliuping paste curing advanced lung cancer \u2013 and clinical analysis of 339 cases. Tradit Chin Med. 1991;4:21.","journal-title":"Tradit Chin Med"},{"key":"e_1_3_5_91_1","first-page":"283","article-title":"The clinical observation of the TCM treatment of NSCLC","volume":"5","author":"Tang WX","year":"1994","unstructured":"Tang WX, Zhang ZQ, Lin HS, et al. The clinical observation of the TCM treatment of NSCLC. Tradit Chin Med. 1994;5:283.","journal-title":"Tradit Chin Med"},{"key":"e_1_3_5_92_1","first-page":"254","article-title":"A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine + cisplatin) plus gensing Rg3 in the treatment of advanced non-small cell lung cancer patients","volume":"9","author":"Sun Y","year":"2006","unstructured":"Sun Y, Lin HS, Zhu YZ, et al. A randomized, prospective, multi-centre clinical trial of NP regimen (vinorelbine + cisplatin) plus gensing Rg3 in the treatment of advanced non-small cell lung cancer patients. Chin J Lung Cancer. 2006;9:254.","journal-title":"Chin J Lung Cancer"},{"key":"e_1_3_5_93_1","first-page":"121","article-title":"Evidence-based medical study of TCM on non-small cell lung cancer","volume":"10","author":"Lin HS","year":"2008","unstructured":"Lin HS, Zhang Y. Evidence-based medical study of TCM on non-small cell lung cancer. World Sci Technol. 2008;10:121.","journal-title":"World Sci Technol"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/278917"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.12270"},{"issue":"2","key":"e_1_3_5_96_1","first-page":"115","article-title":"The clinical application value of yiqi jianpi traditional Chinese medicine combined with thermal perfusion chemotherapy combined with TACE in the treatment of liver metastasis of gastric cancer","volume":"35","author":"Li J","year":"2022","unstructured":"Li J, Gu CL. The clinical application value of yiqi jianpi traditional Chinese medicine combined with thermal perfusion chemotherapy combined with TACE in the treatment of liver metastasis of gastric cancer. Western Trad Chinese Med. 2022 Feb 15;35(2):115\u2013118.","journal-title":"Western Trad Chinese Med"},{"issue":"9","key":"e_1_3_5_97_1","first-page":"1051","article-title":"Clinical value of huachansu hepatic artery injection combined with chemotherapy drug thermal perfusion in the treatment of primary liver cancer","volume":"53","author":"Ding KL","year":"2021","unstructured":"Ding KL, Li WJ, Peng PP. Clinical value of huachansu hepatic artery injection combined with chemotherapy drug thermal perfusion in the treatment of primary liver cancer. Inner Mongolia med J. 2021;53(9):1051\u20131053.","journal-title":"Inner Mongolia med J"},{"issue":"1","key":"e_1_3_5_98_1","first-page":"227","article-title":"The effect of Fu He Bei Hua Fang combined with FOLFOX4 regimen of hepatic artery infusion chemotherapy on the levels of AFP, CEA, and TSGF in primary liver cancer","volume":"39","author":"Jiang ZC","year":"2021","unstructured":"Jiang ZC, Wang TB, Zhong SQ, et al. The effect of Fu He Bei Hua Fang combined with FOLFOX4 regimen of hepatic artery infusion chemotherapy on the levels of AFP, CEA, and TSGF in primary liver cancer. Med Health Techn. 2021 Jan 10;39(1):227\u2013231.","journal-title":"Med Health Techn"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e318162f57d"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22532"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2014.2714"},{"issue":"1","key":"e_1_3_5_102_1","first-page":"58","article-title":"Clinical study of FOLFOX regimen for the patients with advanced hepatocellular carcinoma","volume":"10","author":"Qin SK","year":"2005","unstructured":"Qin SK, Cao MR, Qian J, et al. Clinical study of FOLFOX regimen for the patients with advanced hepatocellular carcinoma. J Chin Clin Oncol. 2005;10(1):58\u201360.","journal-title":"J Chin Clin Oncol"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S304857"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2010.28.15_suppl.4008"},{"issue":"11","key":"e_1_3_5_105_1","first-page":"1141","article-title":"Diagnosis, management, and treatment of hepatocellular carcinoma (V2011)","volume":"27","author":"National Health and Family Planning Commission of PRC","year":"2011","unstructured":"National Health and Family Planning Commission of PRC. Diagnosis, management, and treatment of hepatocellular carcinoma (V2011). J Clin Hepatol. 2011;27(11):1141\u20131159.","journal-title":"J Clin Hepatol"},{"issue":"15","key":"e_1_3_5_106_1","first-page":"38","article-title":"Clinical efficacy of camrelizumab combined with radiofrequency ablation and FOLFOX regimen in the treatment of patients with primary hepatocellular carcinoma","volume":"30","author":"Zhu FT","year":"2021","unstructured":"Zhu FT, Zeng JZ, Jiang JW, et al. Clinical efficacy of camrelizumab combined with radiofrequency ablation and FOLFOX regimen in the treatment of patients with primary hepatocellular carcinoma. China Pharmaceuticals. 2021;30(15):38\u201341.","journal-title":"China Pharmaceuticals"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-23-0060"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.929141"},{"issue":"11","key":"e_1_3_5_109_1","first-page":"5455","article-title":"Clinical efficacy of HAIC (FOLFOX) combined with lenvatinib plus PD-1 inhibitors vs. TACE combined with lenvatinib plus PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas","volume":"13","author":"Lin Z","year":"2023","unstructured":"Lin Z, Chen D, Hu X, et al. Clinical efficacy of HAIC (FOLFOX) combined with lenvatinib plus PD-1 inhibitors vs. TACE combined with lenvatinib plus PD-1 inhibitors in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas. Am J Cancer Res. 2023;13(11):5455\u20135465.","journal-title":"Am J Cancer Res"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0847"},{"key":"e_1_3_5_111_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.542"},{"issue":"9","key":"e_1_3_5_112_1","first-page":"725","article-title":"Comparison and interpretation of international diagnostic guidelines and domestic diagnostic and treatment norms for hepatocellular carcinoma","volume":"52","author":"Li RK","year":"2018","unstructured":"Li RK, Yan FH. Comparison and interpretation of international diagnostic guidelines and domestic diagnostic and treatment norms for hepatocellular carcinoma. Chinese J Rad. 2018 Sep;52(9):725\u2013728.","journal-title":"Chinese J Rad"},{"issue":"6","key":"e_1_3_5_113_1","first-page":"618","article-title":"Chinese expert consensus on conversion therapy in hepatocellular carcinoma (2021 edition)","volume":"41","author":"Sun HZ","year":"2021","unstructured":"Sun HZ, Jia WD, Wang Z, et al. Chinese expert consensus on conversion therapy in hepatocellular carcinoma (2021 edition). Chinese J Practical Surg. 2021;41(6):618\u2013632.","journal-title":"Chinese J Practical Surg"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00608"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(16)30569-1"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11101041"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00326-6"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2024.2346624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T19:27:46Z","timestamp":1727206066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2024.2346624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":115,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,2]]}},"alternative-id":["10.1080\/14737140.2024.2346624"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2024.2346624","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"value":"1473-7140","type":"print"},{"value":"1744-8328","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-02-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}